Medtech Financings, January/February 2009

 

This list of recent financings in medtech, updated from a prior blog post, represents the first in what will be a sort of resurrection of the Financings feature that used to be part of our MedMarkets publication.  As was done in that publication, these listings of financings will eventually have similar detail: who the investors are, the company principals and consistent details on each company’s product/technology.
  • Mpex Pharmaceuticals Announces Series D Financing of Up to $40 Million
  • ALung Technologies raises $1mm of potential $2.5mm financing
  • SynergEyes, Inc. Raises $13.3 Million in ‘Series C’ Financing
  • Arcxis Biotechnologies(R) Secures Series B Financing (undisclosed amount)
  • Diagnosoft(R) Secures $4 Million in Financing
  • DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
  • The Foundry Announces New Partners and Completion of Series A Financing for Eleventh Company
  • Medical device co SteadyMed raises $2M
  • Avantis Medical Systems, Inc. Raises $10 Million in Series C Funding
  • Hydra Biosciences Raises $22 Million in Series D Financing
  • Alter-G Secures $8 Million in Series B Financing from Versant Ventures
  • Singulex Closes $19 Million Financing Round
  • InSet Technologies Completes $25 Million Financing
  • Acclarent, Inc. Closes $26 Million Financing
  • Kythera Biopharmaceuticals [aesthetic dermatology] Secures Additional $10 Million, as part of $40 million Series C
  • Algeta ASA (Oslo, Norway) [cancer therapeutics] receives $35 million in private placement
  • Opsona Therapeuticss [biotech treatment/prevention of autoimmune and inflammatory diseases] receives $23 million Series B
  • Andromeda Biotech receives $10.5 million in funding from Teva Pharmaceutical Industries for juvenile diabetes treatment
  • Ascension Orthopedics secured $21 million in a Series D financing in January



 

1 thought on “Medtech Financings, January/February 2009”

Leave a Reply